Invert

Invert

Biomanufacturing solutions for sustainable materials

About Invert

Simplify's Rating
Why Invert is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Rating Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Company Size

11-50

Company Stage

Early VC

Total Funding

$20.2M

Headquarters

San Francisco, California

Founded

2021

Overview

InvertBio focuses on biomanufacturing, which uses biological processes to produce materials and chemicals. This method allows industries like manufacturing, agriculture, and pharmaceuticals to create physical inputs in a more sustainable and efficient way, reducing environmental impact and costs. InvertBio's technology is scalable, meaning it can grow to meet increasing demand. The company aims to address global challenges such as climate change and poverty by providing a viable alternative to traditional manufacturing processes. Its goal is to lead the transition towards greener industrial practices by offering its biomanufacturing technology and services to various sectors.

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • InvertBio raised $20.1M to expand and accelerate product development.
  • Growing interest in bio-based materials aligns with InvertBio's sustainability focus.
  • Increased venture capital investment indicates strong growth potential in biomanufacturing.

What critics are saying

  • Technological advancements could render InvertBio's platform obsolete if not updated.
  • Data privacy regulations may limit microbial genomics and bioprocess data integration.
  • Intensifying competition in biomanufacturing could erode InvertBio's market share.

What makes Invert unique

  • Invert connects microbial genomics with bioprocess data, eliminating data silos.
  • InvertBio focuses on sustainable biomanufacturing, addressing global challenges like climate change.
  • Invert's platform enables bioindustrial companies to analyze process data without coding.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$20.1M

Above

Industry Average

Funded Over

1 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Benefits

Remote Work Options

Unlimited Paid Time Off

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

↑ 13%

1 year growth

↑ 13%

2 year growth

↑ 16%
Intelligence360
Jul 24th, 2024
Invert Has Filed A Notice Of An Exempt Offering Of Securities To Raise $20,100,000.00 In New Equity Investment.

Invert has filed a notice of an exempt offering of securities to raise $20,100,000.00 in New Equity Investment. Invert has filed a notice of an exempt offering of securities to raise $20,100,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, Invert is raising up to $20,100,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Martin Permin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About InvertInvert builds software for bioprocessing. With Invert, your team has full transparency into all your bioprocess data from lab to production, including full process traceability from upstream to formulation. Your team will save time juggling manual data, get to insights faster, and collaborate seamlessly across teams and partners

U.S. Securities and Exchange Commission
Jul 13th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Forbes
Jul 24th, 2023
There Is No Problem Biology Can'T Solve…Except For Economics

Reptile8488 (Canva)Do you remember when the first fully electric vehicles came out in the early 2000s, and we all said, "Neat, but where are you going to plug it in?" Now—pause for emphasis—a full two decades later—electric vehicles are starting to become commonplace, but they still only account for about 1% of US auto sales.Electricity is cool, as long as it doesn't come from burning coal, but what if our fuel sources could be not only carbon neutral but actually carbon negative? That is the promise of biology.Yeast, bacteria, plants, and algae can use a huge variety of fuel sources—sugar, organic waste, and even greenhouse gases – to produce molecules that we can use for fuel, medicine, plastics, building materials, clothing, cosmetics, and more."It requires a bunch of tinkering and some cell engineering. But you can get [microorganisms] to consume basically anything and make basically anything," said Joshua Lachter, Co-Founder of Synonym Bio, a financing and development platform for biomanufacturing. "That's the idea, the hope, and the dream.". SynBioBetaSynthetic biologists at universities and companies around the world have shown that we can use biomanufacturing to produce hundreds of materials that are currently unsustainably sourced. So, what's the hold-up?For electric vehicles to become more ubiquitous, two shifts have occurred: One in economics, fuel prices went up, and the cost of manufacturing electric vehicles went down; One in infrastructure, EV charging stations popped up everywhere from condos to coffee shops.In order for biomanufacturing to reach its full potential, we have to build an infrastructure, and it's got to be cheap

Recently Posted Jobs

Sign up to get curated job recommendations

Implementation Manager

Remote in USA + 1 more

Invert is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Invert's jobs every few hours, so check again soon! Browse all jobs →

Invert is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Invert's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Invert

Synonym

Synonym

New York City, New York

ElevateBio

ElevateBio

Waltham, Massachusetts

Debut

Debut

San Diego, California